======= ADPRHL2 ======= == Gene Information == * **Official Symbol**: ADPRS * **Official Name**: ADP-ribosylserine hydrolase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54936|54936]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NX46|Q9NX46]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ADPRHL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ADPRHL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610624|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Poly(ADP-ribose) synthesized after DNA damage is only present transiently and is rapidly degraded by poly(ADP-ribose) glycohydrolase. Poly(ADP-ribose) metabolism may be required for maintenance of the normal function of neuronal cells. Generates ADP-ribose from poly-(ADP-ribose), but does not hydrolyze ADP- ribose-arginine, -cysteine, -diphthamide, or -asparagine bonds. Due to catalytic inactivity of PARG mitochondrial isoforms, ARH3 is the only PAR hydrolyzing enzyme in mitochondria. {ECO:0000269|PubMed:16278211}. |ADP ribosyl GH| |peptidyl-serine ADP-deribosylation| |ADP-ribosylserine hydrolase activity| |poly(ADP-ribose) glycohydrolase activity| |O-acetyl-ADP-ribose deacetylase activity| |protein de-ADP-ribosylation| |hydrolase activity, hydrolyzing O-glycosyl compounds| |cellular response to superoxide| |cellular response to oxygen radical| |response to superoxide| |response to oxygen radical| |site of DNA damage| |cellular response to reactive oxygen species| |response to reactive oxygen species| |magnesium ion binding| |cellular response to oxidative stress| |nuclear body| |mitochondrial matrix| |response to oxidative stress| |DNA repair| |response to inorganic substance| |DNA metabolic process| |cellular response to DNA damage stimulus| |cellular response to oxygen-containing compound| |mitochondrion| |response to oxygen-containing compound| |cellular response to stress| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.78| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|2.01| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|2.04| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|3.57| |[[:results:exp512|Olaparib 4μM R08 exp512]]|5.99| ^Gene^Correlation^ |[[:human genes:p:parp1|PARP1]]|0.434| |[[:human genes:r:rrm1|RRM1]]|0.409| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2647 * **Expression level (log2 read counts)**: 4.46 {{:chemogenomics:nalm6 dist.png?nolink |}}